Rocket Pharmaceuticals (RCKT) Stock Highlights

11.56 | +1.85%

2024-12-21 03:54:19

Rocket Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

Statistics

Range Today

11.15 11.79

Volume Today 2.87M

Range 1 Year

11.27 32.53

Volume 1 Year 210.93M

Range 3 Year

7.57 32.53

Volume 3 Year 640.5M

Range 10 Year

3.4 77.8

Volume 10 Year 1.14B

Highlights

Market Capitalization 1.59B (small)

Floating Shares 71.04M

Current Price 11.56

Price To Earnings -6.17

Price To Book 4.82

Earnings Per Share -2.8

Payout Ratio 0%

Performance

Latest +1.85%

1 Month -11.35%

3 Months -45.7%

6 Months -43.83%

1 Year -59.79%

3 Years -48.25%

5 Years -48.69%

10 Years -52.62%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.